Y-Intercept (HK)’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-55,595
Closed -$121K 1485
2024
Q1
$121K Buy
+55,595
New +$121K 0.01% 1257